Cracking Down on Killer Drugs: Dora Akunyili and the Nigerian Success Story

Counterfeit and substandard medicines pose an increasing threat to global health, especially in the developing world. They kill hundreds of thousands--maybe millions--every year, undermine incentives for research and development for new drugs, and are even beginning to infiltrate North American markets.

What can national governments and concerned individuals do to combat this growing menace? Nigeria offers a powerful model. Prior to 2002, over half the medicines traded in Nigeria were thought to be counterfeit. Today, that number is under 20 percent and falling, a remarkable reversal that owes a great deal to Dora Akunyili. As director general of the country's National Agency for Food and Drug Administration and Control (NAFDAC), Akunyili has spearheaded a campaign emphasizing more aggressive policing and more rigorous commitment to prosecuting counterfeiters--and she has succeeded in cracking down on the deadly trade.

AEI, in association with the Heritage Foundation, will host Akunyili to discuss lessons learned and ways forward for other countries threatened by counterfeit drugs. Tom Woods of Heritage will introduce Akunyili, and her presentation will be followed by discussion moderated by AEI's Roger Bate, whose book, Making a Killing: The Deadly Implications of the Counterfeit Drug Trade (AEI Press), will be published in May.

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

Roger
Bate

What's new on AEI

How the Common Core went wrong
image Election countdown: The mood, measurements, and mechanics
image Rubio's defense speech: Fearless, informed, and refreshing
image Sorry Kerry, there is little role for Iran in fighting ISIS
AEI on Facebook
Events Calendar
  • 22
    MON
  • 23
    TUE
  • 24
    WED
  • 25
    THU
  • 26
    FRI
Monday, September 22, 2014 | 2:30 p.m. – 4:00 p.m.
Policy implications of the new US labor market normal

We welcome you to join us as a panel of economists discuss US wage and price prospects in the coming months and the implications for the Federal Reserve’s current unorthodox monetary policy.

Event Registration is Closed
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.